Wells Fargo bank location in Baltimore, MD. August 20, 2020.
A federal judge in Minnesota on Monday dismissed an ERISA lawsuit brought by former Wells Fargo employees against the company for breach of fiduciary duty.
The lawsuit, filed last summer, argued that the company mismanaged its employee prescription drug benefits program, causing participants to pay “substantially more in premiums and out-of-pocket costs for certain prescription drug benefits than they would have absent Wells Fargo’s mismanagement.” The case outlined how Wells Fargo used Express Scripts as its pharmacy benefit manager without competitive bidding and permitted enormous markups, such as charging the plan more than $1,800 for a cancer drug that pharmacies acquired for less than $100.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.